68 search results for the keyword medicine supply notification in latest news
Brexit: DHSC plans for end of Transition Period
The Department of Health and Social Care (DHSC) has clarified its plans for the continuity of supply of medicines and medical goods after the end of the Brexit Transition Period. In a letter to suppliers of medicines and medicinal products,...
Medicine Supply Notification: Ranitidine all formulations – Update
Update: 31.03.2021 All preparations of ranitidine (tablets, effervescent tablets, oral solution and injection) are out of stock until further notice. Following recent advice from the EMA, the MHRA have suspended all licenses for ranitidine products. Department of Health and Social Care...
Medicine supply notification: Stanek® and Sastravi® (levodopa/carbidopa/ entacapone) tablets
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Stanek® and Sastravi® (levodopa/carbidopa/entacapone) tablets – various strengths Teva and Accord the suppliers of Stanek® tablets and Sastravi® (various strengths) are out of stock. The anticipated...
Medicine Supply Notification: Desmopressin (Octim) 150mcg per actuation nasal spray (Ferring Pharmaceuticals)
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Desmopressin (Octim) 150mcg per actuation nasal spray (Ferring Pharmaceuticals) • Desmopressin (Octim®) 150 micrograms per actuation nasal spray is out of stock until mid-2021. • Ferring...
Medicine Supply Notification: Fluoxetine 30mg capsules (Advanz)
Update: (14/01/2020) resupply now expected End of March 2021 Department of Health and Social Care (DHSC) has today issued a medicine supply notification for Fluoxetine 30mg capsules (Advanz) Advanz, the sole supplier, are out of stock of fluoxetine 30mg...
Medicine Supply Notification: Diamorphine hydrochloride powder for reconstitution and injection 5mg and 10mg ampoules
Department of Health and Social Care (DHSC) has issued a Medicine Supply Notification (MSN) for Diamorphine hydrochloride powder for reconstitution and injection 5mg and 10mg ampoules MSN/2021/021 Tier 2 – medium impact Date of issue: 09/04/2021 There are very limited...
Medicine Supply Notification: Rifadin (rifampicin) 100mg/5ml oral suspension (Sanofi)
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Rifadin (rifampicin) 100mg/5ml oral suspension (Sanofi) Sanofi have limited supplies of Rifadin 100mg/5ml oral suspension with resupply expected w/c 18 January 2021 Until 18 January 2021,...
Medicine Supply Notification: Zonisamide 25mg, 50mg and 100mg capsules
Update (28/10/2020) – Due to changes in the availability of Zonisamide capsules from Teva UK and Glenmark Pharmaceuticals, there is updated information in the table below. Product Supplier Current stock position Anticipated resupply date Zonisamide 25mg capsules Eisai In stock...
Medicine Supply Notification: Phytomenadione (Konakion MM Paediatric) 2mg/0.2ml ampoules (Cheplapharm) – Update
Update – 11/01/2021 UK licensed Konakion MM Paediatric will be out of stock until w/c 25th January 2021 Unlicensed supplies are available to support during this time From w/c 25th January 2021 onwards. UK licensed generic phytomenadione 2mg/0.2ml injection will...